Keyphrases
Sustained Release
100%
Poly(lactic-co-glycolic acid)
100%
Dichloromethane
100%
Flavopiridol
100%
Green Approach
100%
Polymer Microparticles
100%
Microparticles
50%
Drug Delivery
50%
Conventional Emulsion
50%
Environmental Toxicity
50%
Dimethyl Carbonate
50%
E-factor
50%
Order of Magnitude
25%
High Biocompatibility
25%
Kinase Inhibitor
25%
Anticancer Therapy
25%
Sustained Delivery
25%
Organic Phase
25%
Particle Size
25%
Release Profile
25%
Degradation Rate
25%
Activity Test
25%
Fast Degradation
25%
Cytotoxicity Test
25%
GlaxoSmithKline
25%
High Efficacy
25%
Conventional Counterpart
25%
Narrow Distribution
25%
Slower Degradation
25%
Post-traumatic Osteoarthritis
25%
Greenness
25%
Microfluidic Flow Focusing
25%
Green Solvent
25%
LD50 Value
25%
High Sustainability
25%
Pharmacology, Toxicology and Pharmaceutical Science
Sustained Release
100%
Microparticle
100%
Polyglactin
100%
Dichloromethane
100%
Flavopiridol
100%
Environmental Toxicity
50%
Malignant Neoplasm
25%
Cytotoxicity
25%
Biocompatibility
25%
Phosphotransferase Inhibitor
25%
Cyclic AMP Dependent Protein Kinase
25%
Osteoarthritis
25%